News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Michail Ignatiadis: Join us tomorrow with ⁦Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib
Michail Ignatiadis/X
Sep 15, 2023, 18:51

Michail Ignatiadis: Join us tomorrow with ⁦Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib

Quoting Michail Ignatiadis, Jules Bordet Institute, on Twitter:

“Join us tomorrow with ⁦Peter Fasching, Sara Tolaney and Stephen Johnston to discuss QoL in the phase 3 NATALEE trial of adjuvant ribociclib, ESMO Virtual Plenary with AACR Expert Commentary: September 2023″

For details click here.
Source: Michail Ignatiadis/Twitter

cancer Michail ignatiadis OncoDaily Oncology Sara Tolaney Stephen Johnston ⁦Peter Fasching
Special Coverage
Blog
Apr 19, 2025, 21:04
Jasmine Kamboj Hosts Policy Webinar with Expert Panel on May 2
Blog
Apr 19, 2025, 20:48
Palliative Care Knowledge in ICUs: Bilal Awad Publishes Q1 Research
Blog
Apr 19, 2025, 20:25
Breast Density Reporting Urged by Lobular Ireland Founder Siobhan Freeney
Blog
Apr 19, 2025, 20:05
Suzette DiMascio: I reflect on a moment that changed my life - and helped save another
Blog
Apr 19, 2025, 19:36
Pranati Yadlapalli Presents Nerve Injury Research at National Conference
Blog
Apr 19, 2025, 19:17
Yelak Biru: Rahul Banerjee on redefining 'cure' in myeloma
Science
Apr 19, 2025, 19:01
Stephen Liu: Perspective on unintended consequences of patient portal access
Blog
Apr 19, 2025, 18:46
Estela Rodriguez: Honored to join thought leaders seeking solutions in biomarker testing
Blog
Apr 19, 2025, 18:42
Pediatric Exercise Oncology Conference 2026: Save the Date - FORTEe
Insight
Apr 19, 2025, 18:29
ESMO living guidelines on metastatic breast cancer
Blog
Apr 19, 2025, 18:20
Todd Davis: Ligand Pharmaceuticals announces agreement to combine Pelthos with Channel Therapeutics
Blog
Apr 19, 2025, 18:05
Prasad Raj Dandekar: A detailed conversation about immunotherapy with Sewanti Limaye